Stocks and Investing
Stocks and Investing
Wed, December 21, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, December 20, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Naz Rahman Maintained (VKTX) at Strong Buy with Increased Target to $15 on, Dec 20th, 2022
Naz Rahman of Maxim Group, Maintained "Viking Therapeutics, Inc." (VKTX) at Strong Buy with Increased Target from $10 to $15 on, Dec 20th, 2022.
Naz has made no other calls on VKTX in the last 4 months.
There is 1 other peer that has a rating on VKTX. Out of the 1 peers that are also analyzing VKTX, 0 agree with Naz's Rating of Hold.
This is the rating of the analyst that currently disagrees with Naz
- Steven Seedhouse of "Raymond James" Maintained at Buy with Increased Target to $11 on, Thursday, October 27th, 2022
Contributing Sources